Will Recent News Hurt JPMorgan Chase’s Stock?

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

With shares of JPMorgan Chase & Co. (NYSE:JPM) trading around $56, is JPM an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

JPMorgan Chase is a financial holding company that provides various financial services worldwide. The company is engaged in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, asset management, and private equity. Financial services companies like JPMorgan Chase are essential for well-functioning economies around the world.

JPMorgan Chase CEO Jamie Dimon, a feisty leader who steered the banking company through the perils of the Great Recession, is battling throat cancer. The condition is considered to be curable, according to a memo to JPMorgan Chase employees and shareholders that Dimon released late Tuesday. Dimon, 58, said he plans to remain on the job and be actively involved in key decisions while undergoing radiation and chemotherapy treatment. The eight-week treatment will begin soon at Memorial Sloan Kettering Hospital in New York. The cancer remains confined to Dimon’s throat and adjacent lymph nodes on the right side of his neck, according to the memo. “I feel very good now and will let all of you know if my health situation changes,” Dimon said.

Despite the words of reassurance, Dimon’s illness could raise leadership concerns at one of the world’s biggest banks. Those worries could be magnified by a recent succession of departures among high-ranking JPMorgan Chase executives once considered to be Dimon’s potential successor. The list of defections have included former co-chief operating officer Frank Bisignano and former investment banking head Michael Cavanagh, who had been known as Dimon’s “Mr. Fix-it.” Dimon, JPMorgan’s CEO for the past eight-and-half years, won praise for his savvy in the aftermath of the mortgage-market meltdown that nearly toppled the banking industry before miring the U.S. in its deepest recession since World War II. His reputation, though, was tarnished in 2012 by the revelation of a stunning $6 billion loss triggered by risky bets made on complex debt securities by a JPMorgan trader in London.

The setback, known as JPMorgan’s “London Whale,” contributed to an unsuccessful shareholder campaign last year to separate the jobs of chairman and CEO — duties that Dimon still holds. JPMorgan also reached a settlement with the U.S. Justice Department last year that required the bank to pay $13 billion to cover losses from the sale of toxic mortgages that later collapsed in value. Another legal settlement negotiated last year required JPMorgan to dole out $4.5 billion to investors in bundles of shoddy home loans. JPMorgan said most of those troublesome mortgages were inherited from investment bank Bear Stearns and savings and loan Washington Mutual, companies that Dimon negotiated to buy during the financial crisis of 2008.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business